| This article has been cited by |
| 1 | Sitagliptin relieves diabetic nephropathy fibrosis via the MAPK/ERK signaling pathway | |
| Shufeng Cheng,Liang Li,Chunquan Song,Huijing Jin,Shouguo Ma,Ping Kang |
| Minerva Endocrinologica.2020;45(3) |
| [DOI] |
|
| 2 | Activation of Spinal Glucagon-Like Peptide-1 Receptors Specifically Suppresses Pain Hypersensitivity | |
| Nian Gong,Qi Xiao,Bin Zhu,Chang-Yue Zhang,Yan-Chao Wang,Hui Fan,Ai-Niu Ma,Yong-Xiang Wang |
| The Journal of Neuroscience.2014;34(15)5322 |
| [DOI] |
|
| 3 | Virtual Screening, Synthesis, and Biological Evaluation of Some Carbohydrazide Derivatives as Potential DPP-IV Inhibitors | |
| Prerana B. Jadhav,Shailaja B. Jadhav,Mehrukh Zehravi,Mohammad S. Mubarak,Fahadul Islam,Philippe Jeandet,Sharuk L. Khan,Nazmul Hossain,Salma Rashid,Long Chiau Ming,Md. Moklesur Rahman Sarker,Mohd Fahami Nur Azlina |
| Molecules.2022;28(1)149 |
| [DOI] |
|
| 4 | Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study) | |
| Masaya Sakamoto,Rimei Nishimura,Taiga Irako,Daisuke Tsujino,Kiyotaka Ando,Kazunori Utsunomiya |
| Cardiovascular Diabetology.2012;11(1)92 |
| [DOI] |
|
| 5 | HL-7 and HL-10 Peptides Stimulate Insulin Secretion in the INS-1 Insulinoma Cell Line through Incretin-Dependent Pathway and Increasing the Glucose Uptake in L6 Myoblast | |
| Zahra Setayesh-Mehr,Mahdiye Poorsargol |
| International Journal of Peptide Research and Therapeutics.2021;27(4)2231 |
| [DOI] |
|
| 6 | Flavonoid rich fraction of Pilea microphylla (L.) attenuates metabolic abnormalities and improves pancreatic function in C57BL/KsJ-db/db mice | |
| P. Bansal,P. Paul,G. Shankar,D. Munjal,P.G. Nayak,K.I. Priyadarsini,M.K. Unnikrishnan |
| Biomedicine & Preventive Nutrition.2011;1(4)268 |
| [DOI] |
|
| 7 | Alkaloid Fraction of Litsea glutinosa Leaves Provides an Important Precursor for Inhibition of Dipeptidyl Peptidase 4 Activity | |
| S W Kisnawaty,P Nityasewaka,B A R Sukma,A V Putrinadia,T Ma’rifah,D G Tamtomo,D Indarto |
| IOP Conference Series: Materials Science and Engineering.2019;546(6)062013 |
| [DOI] |
|
| 8 | Influence of the cellular environment on ligand binding kinetics at membrane-bound targets | |
| Patrick M.L. Vanderheyden,Nerdjes Benachour |
| Bioorganic & Medicinal Chemistry Letters.2017;27(16)3621 |
| [DOI] |
|
| 9 | Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice | |
| Andrew G. McCloskey,Michael G. Miskelly,Ryan A. Lafferty,Peter R. Flatt,Aine M McKillop |
| Biochemical Pharmacology.2023;208(16)115398 |
| [DOI] |
|
| 10 | Circulating Dipeptidyl Peptidase Activity Is a Potential Biomarker for Inflammatory Bowel Disease | |
| Simone E. Jaenisch,Catherine A. Abbott,Mark D. Gorrell,Peter Bampton,Ross N. Butler,Roger Yazbeck |
| Clinical and Translational Gastroenterology.2022;13(1)e00452 |
| [DOI] |
|
| 11 | Circulating Dipeptidyl Peptidase Activity Is a Potential Biomarker for Inflammatory Bowel Disease | |
| Shujaath Mehdi |
| Clinical and Translational Gastroenterology.2013;13(1)81 |
| [DOI] |
|
| 12 | Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis | |
| A.G. McCloskey,M.G. Miskelly,P.R. Flatt,A.M. McKillop |
| European Journal of Pharmaceutical Sciences.2020;142(1)105104 |
| [DOI] |
|
| 13 | Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial | |
| Wolfgang Kothny,Valentina Lukashevich,James E. Foley,Marc S. Rendell,Anja Schweizer |
| Diabetologia.2015;58(9)2020 |
| [DOI] |
|
| 14 | DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature | |
| Kunika Saini,Smriti Sharma,Yousuf Khan |
| Frontiers in Molecular Biosciences.2023;10(9)2020 |
| [DOI] |
|
| 15 | CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function | |
| A.G. McCloskey,M.G. Miskelly,C.B.T. Moore,M.A. Nesbit,K.A. Christie,A.I. Owolabi,P.R. Flatt,A.M. McKillop |
| Peptides.2020;125(9)170251 |
| [DOI] |
|
| 16 | Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans | |
| B. Ahrén,A. Schweizer,S. Dejager,E. B. Villhauer,B. E. Dunning,J. E. Foley |
| Diabetes, Obesity and Metabolism.2011;13(9)775 |
| [DOI] |
|
| 17 | Target-mediated metabolism and target-mediated drug disposition of the DPPIV inhibitor AMG 222 | |
| Robert J. Greene,Hua Tu,John P. Gibbs,J. Greg Slatter |
| Xenobiotica.2011;41(11)945 |
| [DOI] |
|
| 18 | Synthesis, Characterization and Screening of Some Novel 2-Methyl-N'-
[(Z)-Substituted-Phenyl ethylidene] Imidazo [1, 2-a] Pyridine-3-Carbohy
drazide Derivatives as DPP-IV Inhibitors for the Treatment of Type 2 Diabetes
Mellitus | |
| Prerana A. Chavan,Shailaja B. Jadhav |
| Letters in Drug Design & Discovery.2022;19(2)160 |
| [DOI] |
|
| 19 | A novel self-sufficient biocatalyst based on transaminase and pyridoxal 5'-phosphate covalent co-immobilization and its application in continuous biosynthesis of sitagliptin | |
| Xiao-Jian Zhang,Hao-Hao Fan,Nan Liu,Xin-Xin Wang,Feng Cheng,Zhi-Qiang Liu,Yu-Guo Zheng |
| Enzyme and Microbial Technology.2019;130(2)109362 |
| [DOI] |
|
| 20 | Stability of extemporaneously prepared sitagliptin phosphate solution | |
| Abdel Naser Zaid,Yara Abu Zaaror,Aiman Kaddumi,Mashhour Ghanem,Nidal Jaradat,Tharaa Abu Salah,Sameera Siaj,Lana Omari,Girish Sailor |
| PLOS ONE.2022;17(3)e0262068 |
| [DOI] |
|
| 21 | The effect of CD26-deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease | |
| Suncica Buljevic,Dijana Detel,Ester P. Pugel,Jadranka Varljen |
| Journal of Cellular Biochemistry.2018;119(8)6743 |
| [DOI] |
|
| 22 | Effects of vildagliptin as add-on treatment in patients with type 2 diabetes mellitus: insights from long-term clinical studies in Japan | |
| Masato Odawara,Rieko Sagara |
| Journal of Diabetes & Metabolic Disorders.2015;15(1)6743 |
| [DOI] |
|
| 23 | Glucose regulation by newly synthesized boronic acid functionalized molecules as dipeptidyl peptidase IV inhibitor: a potential compound for therapeutic intervention in hyperglycaemia | |
| Namrata Prajapati,Dilip Sharma,Pankaj Ashok Bidve,Deepak Chouhan,Meghana Allani,Sagar kumar Patel,Moumita Ghosh Chowdhury,Amit Shard,Vinod Tiwari |
| Journal of Biomolecular Structure and Dynamics.2023;15(1)1 |
| [DOI] |
|
